Tuesday, July 22, 2014 Last update: 9:33 PM
FreshNews.com - All Company Technology News Since 1996

Toshiba Introduces New Patient-Friendly PET/CT System

Companies mentioned in this article: Toshiba America Medical Systems, Inc.

TUSTIN, Calif. -- (BUSINESS WIRE) -- Oncology departments can now provide their patients with a better PET/CT imaging experience using Toshiba America Medical Systems, Inc.’s all-new Celesteion (pending 510(k) clearance). The versatile system combines high performance PET and CT for all radiation and oncology imaging needs, including tumor detection, treatment evaluation and CT simulation.

As healthcare reform puts a greater emphasis on patient satisfaction, the Celesteion’s numerous patient-friendly features are designed for this new landscape. These include:

  • Industry’s Largest Bore 90 cm CT and 88 cm PET bore offers a feeling of openness for patients, and more accurate CT and PET imaging
  • Fast Imaging For reduced exam times
    • PET – 450 ps time-of-flight resolution
    • CT – 0.5 second rotation with 0.5 mm detectors producing 32 slices
  • Expansive Field-of-View 70 cm true CT and PET field-of-view and 85 cm CT extended field-of-view
  • CT Dose Reduction Ensuring that patient safety is not a choice, Celesteion comes standard with Toshiba’s most advanced CT dose reduction technology, AIDR 3D, for safer CT imaging, and is also compliant with MITA’s XR-29 Smart Dose Standard

“By listening to our customers and understanding their business, we know there is a need for a PET/CT system that puts patients first, and the Celesteion is that solution,” said Satrajit Misra, senior director, CT Business Unit, Toshiba. “Accuracy and efficiency are crucial under healthcare reform, and Celesteion is capable of producing high quality images while improving workflow for providers.”

Toshiba’s Celesteion is being unveiled for the first time at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting, June 7–11, 2014, in St. Louis.

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at www.toshibamedicalsystems.com.

About Toshiba

Toshiba Corporation, a Fortune 500 company, channels world-class capabilities in advanced electronic and electrical product and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future,” Toshiba promotes global operations towards securing “Growth Through Creativity and Innovation,” and is contributing to the achievement of a world in which people everywhere live safe, secure and fulfilled lives.

Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 590 consolidated companies employing over 200,000 people worldwide, with annual sales surpassing 6.5 trillion yen (US$63 billion). To find out more about Toshiba, visit www.toshiba.co.jp/index.htm.


Copyright © Business Wire 2014
Contact:

Toshiba America Medical Systems, Inc.
Rachel Miller, 714-669-7623
rmiller@tams.com
or
Michael Stewart, 310-295-3323
michael.stewart@ketchum.com